According to all these findings, p53 activation may be a broader metabolic event that is significantly involved in the pathogenesis of a fatty liver, which not only facilitates apoptosis and oxidative stress but also generates hepatic abnormalities such as insulin resistance and steatosis. Here, TP53 is linked to fatty liver disease.